Papers
2
Total Citations
23
H-Index
2
About
Ahmad Mousa is a rising surgical oncologist whose research is reshaping the management of testicular cancer, with a particular focus on optimizing surgical outcomes and prognostic accuracy. His work centers on the comparative effectiveness of robotic versus open surgical approaches, as well as the refinement of risk stratification tools for patients with clinical stage II disease. In his most cited study, a propensity-matched analysis of over 21 citations, Mousa demonstrated that robotic primary retroperitoneal lymph node dissection (RPLND) offers comparable oncologic efficacy to open surgery, with the potential for reduced morbidity—a critical insight for young patients facing this procedure. He has also advanced the field by investigating lymph node density as a novel prognostic marker for relapse following RPLND, a contribution that could help tailor postoperative surveillance and adjuvant therapy. Though early in his career, Mousa’s work is already influencing surgical decision-making and patient counseling. His research bridges the gap between minimally invasive innovation and evidence-based oncology, positioning him as a key voice in the evolution of testicular cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2